Trend of Automated External Defibrillators (AED’s) in Public Access Areas Driving The Defibrillator Devices Global Market Growth
Heart is referred as the major organ of human body that plays an important role in maintaining the normal metabolism by pumping the blood throughout the body via the circulatory system, supplying oxygen and nutrients to the tissues and aiding in removal of carbon-di-oxide and others wastes. In order to carry out these functions, systematic heart rhythm play a major role and if rhythms fail, then, the overall function of the body organs becomes abnormal resulting in sudden cardiac arrest and death. Hence, when a patient suffers from irregular heartbeats a life-saving device called defibrillator is used for delivering electrical impulse to heart muscles to regain the normal heart beats. These defibrillator devices are mainly used as therapeutic tools to save the life of a patient immediately after the heart attack and enhance their safety.
In the early days, defibrillation procedures were carried out through cardioversion procedure which needed to be carried out by medical experts and their assistants. But, during sudden cardiac arrest, the patient gets a lifeline of few minutes and if by that time the defibrillation procedure is not carried out, the patient may die. Advancements in defibrillators have reduced the life-threatening complications and have increased the survival rates by providing on the spot timely electrical shocks to heart muscles where irregular heart rhythms are converted into normal heart rhythms. The increase in sudden cardiac deaths and prevalence of cardiovascular diseases are the leading factors that has raised the demand for advanced portable defibrillators and their accessories, thus shifting market players focus more towards research activities, approvals and launch of new products, to innovate new technically advanced defibrillator devices. For instance, in August 2016, Boston Scientific Corporation received FDA approval for its EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD) System as a treatment option for patients with sudden cardiac arrest risks.
The defibrillator devices are classified into implantable cardioverter defibrillators and external defibrillators. Implantable cardioverter defibrillators are the devices implanted in the patients with known or survived ventricular fibrillation for continuous monitoring of heart rhythms and if abnormalities are observed then a message is sent to the patient to opt for defibrillation. In case of, patients who are unaware of their condition and would experience irregular heart rhythms anytime and anywhere needs external defibrillators for providing an electrical shock to the victim’s heart muscle as a part of first aid. In defibrillation procedures, medical experts and their assistants and other users employ different types of defibrillators devices for delivering a shock to patient’s heart muscle and resuscitating the victim. In recent days, most of the defibrillator devices used is fully automated and any layman can use these devices by hearing the audio guidelines.
Technological advancements such as customized defibrillator devices & consumables, leadless defibrillators, ambulance drone and ambulance robotic-assisted AED’s are expected to rule the defibrillator devices market through their special features.
AED’s a type of external defibrillator, have emerged as a useful tool in the cardiovascular therapeutic applications as these devices play a major role in resuscitating the victim of sudden cardiac arrest. According to American Heart Association’s 2016 statistics on sudden cardiac arrest, it is estimated that more than 350,000 people suffered from out of hospital cardiac arrest where patient needed to be resuscitated within 10 minutes of the attack as the patient life line starts declining as every minute passes. In was observed that, in most cases, cardiac arrest happened in public access areas thus increasing demand for automated external defibrillator devices and necessitating for installation of AED’s in public access areas and legalization of compulsory installation of AED’s, thus, use of AED’s in public access areas like airports, shopping malls, cinema theaters, schools, offices and others would be helpful in resuscitating the sudden cardiac arrest victim within 2-3 minutes of the attack and avoid the chances of death.
Some of the AED’s available in the market include Fully Automatic AED Plus by Asahi Kasei Corporation (Japan), SALI- automated wireless PADs by Inovytec Medical Solutions Ltd (Isreal), HeartStart FR3 by Philips Healthcare (Netherlands), LIFEPAK CR Plus AED, SAMARITAN PAD 360P Automatic AED by Stryker Corporation (U.S.), Powerheart G3 Plus AED by Aurora Capital Group (U.S.), Cardiolife AED-2152K by Nihon Kohden Corporation (Japan), Life-Point Pro AED by Metsis Medikal (Turkey), LPM-403 biphasic defibrillator by Life Plus Medical Inc (India), Heart plus AED by Nanoomtech (Korea), Reanibex 800 semi-automatic defibrillator by Bexen Cardio (Spain), ER-5 automatic external defibrillator with ECG and SPO2 monitor by Dixion Vertrieb medizinischer Geräte GmbH (Germany), C-12RS semi-automatic external defibrillator with ECG and SPO2 monitor by E & M Electromedicina (Argentina).
Emerging players in this market includes Metsis Medikal (Turkey), Life Plus Medical Inc (India), Nanoomtech (Korea), Bexen Cardio (Spain), Dixion Vertrieb medizinischer Geräte GmbH (Germany), Electromedicina (Argentina), OrientMEd International FZE by (United Arab Emirates), Emtel (Poland), Mediana (South Korea), M&B Electronic Instruments (Beijing), BPL Medical Technologies (India), CU Medical Systems Inc (Korea), AMI Italia Medical Products (Italy), Instramed (Brazil), Meditech (U.S.), Corpuls (Germany), INNOMED Medical Developing and Manufacturing (Italy), Techno-GAZ (Italy), Yuan Technology Limited (China), US Defib Medical Technologies (U.S.), Mindray (China), Fukuda Denshi (Japan), Schiller (U.S.), MS Westfalia GmbH (Germany), Metrax GmbH (Germany) and Medical Econet GmbH (Germany).
Major players in AED defibrillator devices market include Asahi Kasei Corporation (Japan), Stryker Corporation (U.S.), Philips Healthcare (Netherlands), Nihon Kohden Corporation (Japan) and Aurora Capital Group (U.S.).